FDA seeks more safety data from Lilly on obesity drug Foundayo; Novo partners OpenAI to speed up drug development
This week’s Phispers brings you news on how artificial intelligence (AI) is taking centerstage in the world of pharmaceut...
Impressions : 2333
Advent to sell generic unit to PE firm GTCR for US$ 4.8 billion; Novo shapes up for obesity race by cutting 9,000 jobs
In this week’s news, Advent International has agreed to sell the Czech generic drugmaker Zentiva to private equity firm G...
Impressions : 1215
Consortium makes ~US$ 3 bn offer to buy Bavarian Nordic; FDA approves PTC’s rare genetic disorder drug
The US Food and Drug Administration (FDA) has approved PTC Therapeutics’ oral drug to treat a rare genetic disorder known...
Impressions : 1107
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.